Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 23, 2022

BUY
$11.89 - $19.72 $4,886 - $8,104
411 Added 17.68%
2,736 $50,000
Q1 2022

May 16, 2022

SELL
$10.8 - $23.97 $244,879 - $543,495
-22,674 Reduced 90.7%
2,325 $37,000
Q4 2021

Feb 14, 2022

SELL
$19.83 - $32.24 $114,776 - $186,605
-5,788 Reduced 18.8%
24,999 $586,000
Q3 2021

Nov 16, 2021

SELL
$27.32 - $36.3 $17,430 - $23,159
-638 Reduced 2.03%
30,787 $1 Million
Q2 2021

Aug 16, 2021

SELL
$26.2 - $37.66 $8,619 - $12,390
-329 Reduced 1.04%
31,425 $1.16 Million
Q1 2021

May 17, 2021

BUY
$20.7 - $32.61 $647,992 - $1.02 Million
31,304 Added 6956.44%
31,754 $810,000
Q4 2020

Feb 16, 2021

BUY
$7.21 - $43.36 $2,163 - $13,008
300 Added 200.0%
450 $12,000
Q2 2020

Aug 14, 2020

BUY
$2.97 - $10.78 $445 - $1,617
150 New
150 $6,000

Others Institutions Holding WXXWY

About WUXI BIOLOGICS CAYMAN INC


  • Ticker WXXWY
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,109,670,016
  • Market Cap $14.1B
More about WXXWY
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.